# Acme United Corp: filings

ACU · NYSE · CIK 2098 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/acu.md) · [Financials](/companies/acu/financials.md) · [Filings](/companies/acu/filings.md) · [Insiders](/companies/acu/insiders.md)

## Reports and events: 213 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 450, 8-K 119, 10-Q 53, SC 13G/A 39, 10-K 18, DEF 14A 18, 144 15, S-8 14, SC 13G 12, UPLOAD 10, SCHEDULE 13G/A 9, CORRESP 8, 4/A 7, 5 6, ARS 4, 8-K/A 2, NT 10-K 2, SC 13D 2, 3 1, DEFA14A 1, SC 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 09:18 ET | [8-K](/filings/0001193125-26-432999.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-432999 |
| 2026-08-06 | 16:30 ET | [10-Q](/filings/0001193125-26-338211.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338211 |
| 2026-07-23 | 08:08 ET | [8-K](/filings/0001193125-26-313374.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-313374 |
| 2026-07-21 | 16:15 ET | [8-K](/filings/0001193125-26-310329.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-310329 |
| 2026-05-06 | 16:15 ET | [10-Q](/filings/0001193125-26-209010.md) | Quarterly report, period 2026-03-31 | 0001193125-26-209010 |
| 2026-04-28 | 16:30 ET | [8-K](/filings/0001193125-26-187237.md) | 5.07 Shareholder vote results | 0001193125-26-187237 |
| 2026-04-23 | 09:00 ET | [8-K](/filings/0001193125-26-172010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-172010 |
| 2026-03-27 | 17:18 ET | [DEF 14A](/filings/0001193125-26-129439.md) | Proxy statement, period 2026-04-27 | 0001193125-26-129439 |
| 2026-03-11 | 16:00 ET | [10-K](/filings/0001193125-26-102079.md) | Annual report, period 2025-12-31 | 0001193125-26-102079 |
| 2026-02-26 | 10:27 ET | [8-K](/filings/0001193125-26-074247.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-074247 |
| 2026-01-22 | 17:03 ET | [8-K](/filings/0001193125-26-019610.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001193125-26-019610 |
| 2025-11-06 | 16:00 ET | [10-Q](/filings/0001193125-25-269422.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269422 |
| 2025-10-21 | 09:52 ET | [8-K](/filings/0001193125-25-244419.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-244419 |
| 2025-08-06 | 16:00 ET | [10-Q](/filings/0000950170-25-103966.md) | Quarterly report, period 2025-06-30 | 0000950170-25-103966 |
| 2025-07-23 | 08:13 ET | [8-K](/filings/0000950170-25-097714.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-097714 |
| 2025-07-01 | 16:30 ET | [8-K](/filings/0000950170-25-092258.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-25-092258 |
| 2025-05-07 | 16:00 ET | [10-Q](/filings/0000950170-25-065598.md) | Quarterly report, period 2025-03-31 | 0000950170-25-065598 |
| 2025-04-23 | 16:30 ET | [8-K](/filings/0000950170-25-057453.md) | 5.07 Shareholder vote results | 0000950170-25-057453 |
| 2025-04-17 | 09:20 ET | [8-K](/filings/0000950170-25-055017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-055017 |
| 2025-03-24 | 17:00 ET | [8-K](/filings/0000950170-25-043941.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0000950170-25-043941 |
| 2025-03-24 | 16:30 ET | [DEF 14A](/filings/0001193125-25-061382.md) | Proxy statement, period 2025-04-21 | 0001193125-25-061382 |
| 2025-03-06 | 16:54 ET | [10-K](/filings/0000950170-25-034843.md) | Annual report, period 2024-12-31 | 0000950170-25-034843 |
| 2025-02-28 | 11:00 ET | [8-K](/filings/0000950170-25-029633.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-029633 |
| 2024-11-08 | 16:00 ET | [10-Q](/filings/0000950170-24-124031.md) | Quarterly report, period 2024-09-30 | 0000950170-24-124031 |
| 2024-10-18 | 12:14 ET | [8-K](/filings/0000950170-24-115498.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-115498 |
| 2024-08-08 | 16:21 ET | [10-Q](/filings/0000950170-24-094048.md) | Quarterly report, period 2024-06-30 | 0000950170-24-094048 |
| 2024-07-22 | 17:53 ET | [8-K/A](/filings/0000950170-24-085000.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-085000 |
| 2024-07-19 | 10:30 ET | [8-K](/filings/0000950170-24-084785.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-084785 |
| 2024-05-08 | 16:00 ET | [10-Q](/filings/0000950170-24-055586.md) | Quarterly report, period 2024-03-31 | 0000950170-24-055586 |
| 2024-04-24 | 16:30 ET | [8-K](/filings/0000950170-24-047630.md) | 5.07 Shareholder vote results | 0000950170-24-047630 |
| 2024-04-19 | 10:00 ET | [8-K](/filings/0000950170-24-045741.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-045741 |
| 2024-04-03 | 16:30 ET | [8-K](/filings/0000950170-24-041116.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-24-041116 |
| 2024-03-25 | 10:01 ET | [DEF 14A](/filings/0001193125-24-076105.md) | Proxy statement, period 2024-04-22 | 0001193125-24-076105 |
| 2024-03-07 | 16:00 ET | [10-K](/filings/0000950170-24-027907.md) | Annual report, period 2023-12-31 | 0000950170-24-027907 |
| 2024-03-01 | 10:17 ET | [8-K](/filings/0000950170-24-023566.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-023566 |
| 2023-11-08 | 16:30 ET | [10-Q](/filings/0000950170-23-061188.md) | Quarterly report, period 2023-09-30 | 0000950170-23-061188 |
| 2023-11-02 | 16:30 ET | [8-K](/filings/0000950170-23-058277.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0000950170-23-058277 |
| 2023-10-23 | 11:56 ET | [8-K](/filings/0000950170-23-054531.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-054531 |
| 2023-08-08 | 16:16 ET | [10-Q](/filings/0000950170-23-039835.md) | Quarterly report, period 2023-06-30 | 0000950170-23-039835 |
| 2023-07-21 | 10:30 ET | [8-K](/filings/0000950170-23-033772.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-033772 |
| 2023-05-09 | 16:01 ET | [10-Q](/filings/0001564590-23-007103.md) | Quarterly report, period 2023-03-31 | 0001564590-23-007103 |
| 2023-04-26 | 16:00 ET | [8-K](/filings/0001564590-23-006294.md) | 5.07 Shareholder vote results | 0001564590-23-006294 |
| 2023-04-21 | 10:39 ET | [8-K](/filings/0001564590-23-006014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-23-006014 |
| 2023-03-27 | 16:01 ET | [DEF 14A](/filings/0001193125-23-080419.md) | Proxy statement, period 2023-04-24 | 0001193125-23-080419 |
| 2023-03-10 | 17:11 ET | [10-K](/filings/0001564590-23-003422.md) | Annual report, period 2022-12-31 | 0001564590-23-003422 |
| 2023-03-02 | 12:40 ET | [8-K](/filings/0001564590-23-002988.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-23-002988 |
| 2022-11-09 | 16:01 ET | [10-Q](/filings/0001564590-22-037198.md) | Quarterly report, period 2022-09-30 | 0001564590-22-037198 |
| 2022-10-21 | 10:43 ET | [8-K](/filings/0001564590-22-034822.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-22-034822 |
| 2022-08-08 | 16:33 ET | [10-Q](/filings/0001564590-22-028456.md) | Quarterly report, period 2022-06-30 | 0001564590-22-028456 |
| 2022-07-22 | 12:26 ET | [8-K](/filings/0001564590-22-026244.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-22-026244 |

Page 1 of 5. [Older](/companies/acu/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:40 ET. No prices; not investment advice.